Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LOVENOX for Atrial fibrillation: Side Effects & Safety Data

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

There are 8 adverse event reports in the FDA FAERS database where LOVENOX was used for Atrial fibrillation.

Most Reported Side Effects for LOVENOX

Side Effect Reports % Deaths Hosp.
Injury associated with device 56 11.5% 0 0
Death 23 4.7% 23 6
Deep vein thrombosis 22 4.5% 0 13
Pulmonary embolism 22 4.5% 6 14
Haematoma 21 4.3% 2 14
Exposure during pregnancy 20 4.1% 0 1
Injection site bruising 20 4.1% 1 2
Injection site pain 18 3.7% 1 3
Contusion 17 3.5% 1 2
Thrombosis 16 3.3% 4 9
Injection site haemorrhage 15 3.1% 0 3
Pain 15 3.1% 1 3
Drug ineffective 13 2.7% 1 9
Fatigue 13 2.7% 0 1
Haemorrhage intracranial 11 2.3% 11 10

Other Indications for LOVENOX

Product used for unknown indication (121) Thrombosis (36) Deep vein thrombosis (33) Pulmonary embolism (30) Prophylaxis (20) Thrombosis prophylaxis (18) Cardiovascular disorder (7) Acute coronary syndrome (6) Anticoagulant therapy (6)

Other Drugs Used for Atrial fibrillation

RIVAROXABAN (52,584) DABIGATRAN ETEXILATE (20,492) APIXABAN (10,500) AMIODARONE (9,083) WARFARIN (8,680) EDOXABAN (3,855) ASPIRIN (2,993) DOFETILIDE (2,439) PRADAXA (2,325) METOPROLOL (1,542)

Related Pages

LOVENOX Full Profile All Atrial fibrillation Drugs LOVENOX Demographics LOVENOX Timeline